National Academies Press: OpenBook
« Previous: Appendix C: Statement of Task
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

Appendix D

Registered Attendees

Scott Allocco

BioMarker Strategies

Eric Assaraf

WRG

Erin Balogh

Institute of Medicine

Robert Bast

University of Texas MD Anderson Cancer Center

Jessica Bayh

Applied Policy

Al Benson III

Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Marian Birkeland

National Comprehensive Cancer Network

Mary Bordoni

Personalized Medicine Coalition

Jennifer Bowman

American Clinical Laboratory Association

Pamela Bradley

American Association for Cancer Research

Joel Brill

Predictive Health, LLC

Jeffrey Bush

BD

Khatereh Calleja

AdvaMed

Allen Egon Cholakian

IRDF Project Harvard/Columbia

Deborah Collyar

Patient Advocates in Research

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

Jeff Cossman

USDS, Inc.

Robin Harper Cowie

Biodesix, Inc.

Claude Desjardins

Johns Hopkins Bloomberg School of Public Health

Patricia Deverka

Center for Medical Technology Policy

Vamil Divan

Credit Suisse

Noel Doheny

Epigenomics, Inc.

Sarah Donovan

Avalere

Georgia Dunston

Howard University

Tania Dutta

Center for Medical Technology Policy

Christopher Earl

Innotrove, LLC

Raith Erickson

Complete Genomics

Lloyd Everson

The U.S. Oncology Network

Kelly Filipski

National Cancer Institute

Andrew Freedman

National Cancer Institute

Gwen Gordon

Personalized Medicine Coalition

Daniel Grosu

Illumina, Inc.

Valerie Hutchins

HillCo HEALTH

Usman Iqbal

Sanofi

Ram Iyer

Inova Health Systems

Leila Jamal

Kennedy Krieger Institute

Elaine Jeter

Palmetto GBA

Brett Johnson

International Cancer Advocacy Network

Roger Klein

University of South Florida School of Medicine

Hon-Sum Ko

U.S. Food and Drug Administration

Nicole Kuderer

Duke University

Hanns Kuttner

Hudson Institute

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

Gabriela Lavezzari

Express Scripts

Debra Leonard

Weill Cornell Medical Center

Rachel Lindor

Arizona State University College of Law

Tracy Lively

National Cancer Institute

Gary Lyman

Duke University School of Medicine; Duke Cancer Institute

Julie Lynch

U.S. Department of Veterans Affairs

Elizabeth Mansfield

U.S. Food and Drug Administration

Stephen Marmaras

Biotechnology Industry Organization

Robert McCormack

Veridex, LLC

Robert McDonough

Aetna

Mary McGrane

U.S. Department of Agriculture

Lisa McShane

National Cancer Institute

Kala Menon

Booz Allen Hamilton

Donna Messner

Center for Medical Technology Policy

Douglas Moeller

McKesson Health Solutions

Padmaja Mummaneni

U.S. Food and Drug Administration

Bill Murray

Cepheid

David Nelson

EPIC Sciences

Lee Newcomer

United HealthCare Corporation

R. Hannes Niedner

5AM Solutions, Inc.

Danielle Pambianco

HillCo HEALTH

David Parkinson

Nodality

Scott Patterson

Amgen, Inc.

Edmund Pezalla

Aetna

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

Kathryn Phillips

University of California, San Francisco, Center for Translational and Policy Research on Personalized Medicine

Steve Phurrough

Center for Medical Technology Policy

Margaret Piper

Technology Evaluation Center, Blue Cross Blue Shield Association

Bruce Quinn

Foley Hoag, LLP

Samantha Roberts

Friends of Cancer Research

Jeffrey Roche

Centers for Medicare & Medicaid Services

Greg Rossi

AstraZeneca UK

Drew Saelens

Applied Policy

Howard Scher

Memorial Sloan-Kettering Cancer Center

Richard Schilsky

Comprehensive Cancer Center, University of Chicago

Michele Schoonmaker

Cepheid

Beverlyn Settles-Reaves

Howard University

Paul Sheives

Biotechnology Industry Organization

Naoko Simonds

National Cancer Institute

Mary Lou Smith

Research Advocacy Network

Stuart Spector

Center for Medical Technology Policy

Merianne Spencer

Center for Medical Technology Policy

Sylvia Trujillo

American Medical Association

Sean Tunis

Center for Medical Technology Policy

Jessica Walrath

Friends of Cancer Research

Corinne Warren

Center for Medical Technology Policy

Richard Wenstrup

Myriad Genetic Laboratories

Elizabeth West

FasterCures

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

Wendy Wifler

Agendia, Inc.

Marc Williams

Geisinger Health System

Dara Wright

Affymetrix

Amy Zettle

Potomac Research Group

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×

This page intentionally left blank.

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 97
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 98
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 99
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 100
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 101
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2013. Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/18275.
×
Page 102
Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology: Workshop Summary Get This Book
×
Buy Paperback | $38.00 Buy Ebook | $30.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology is the summary of a workshop convened in May 2012 by the Roundtable on Translating Genomic-Based Research for Health and the Center for Medical Technology Policy of the Institute of Medicine to foster the identified need for further sustained dialogue between stakeholders regarding the clinical utility of molecular diagnostics. The workshop brought together a wide range of stakeholders, including patients, health care providers, policy makers, payers, diagnostic test developers, researchers, and guideline developers, to identify the challenges and opportunities in advancing the development and use of molecular diagnostic tests designed to guide the treatment and management of patients with cancer.

The sequencing of the human genome has greatly accelerated the process of linking specific genetic variants with disease. These findings have yielded a rapidly increasing number of molecular diagnostic tests designed to guide disease treatment and management. Many of these tests are aimed at determining the best treatments for specific forms of cancer, making oncology a valuable testing ground for the use of molecular diagnostic tests in medicine in general. Nevertheless, many questions surround the clinical value of molecular diagnostic tests, and their acceptance by clinicians, payers, and patients has been unpredictable. A major limiting factor for the use of these tests has been the lack of clear evidence of clinical utility. Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!